Primary Job Title Managing Director Primary Organization Longitude Capital
Location Greater New York Area, United States, North America Regions East Coast Gender Male
Investor Type
LinkedIn View on LinkedIn
David Hirsch is a founder and Managing Director of Longitude Capital. He focuses on investments in biotechnology.
From 2005 to 2006, David Hirsch was a Vice President of Pequot Ventures where he worked in the life sciences practice. Prior to Pequot, David Hirsch was an Engagement Manager in the pharmaceutical practice of McKinsey & Company.
While at McKinsey, he worked with many large pharmaceutical companies across a range of projects including clinical and commercial strategies, M&A evaluations, portfolio prioritization and managed care strategy.
He currently serves on the boards of Civitas Therapeutics and Precision Therapeutics and is a board observer at InfaCare Pharmaceuticals and Xanodyne Pharmaceuticals. He is also actively involved with Longitude’s investments in Amarin (NASDAQ: AMRN) and Corcept Therapeutics (NASDAQ: CORT), as well as prior investments in Horizon Therapeutics and Sequenom (NASDAQ: SQNM).
